User:Adam Silverstein2/draftTonyColes

N. Anthony (Tony) Coles is the chairman of the board of directors, president and chief executive officer (CEO) of Onyx_Pharmaceuticals

Family and Early Life
Coles (born 1960) grew up in Washington, D.C, and is the oldest of three children. His father was a government accountant and currently serves as a bishop. His mother was an office manager who worked for what is now AT&T. Coles is married and has three children.

Coles’ oldest son was diagnosed in 2001 with Non-Hodgkin lymphoma when he was 12 years old. He was cured after a bone marrow transplant. Coles says his son's experience has given him a deeper understanding about the impact Onyx could have in helping patients and their families.

Education
Coles completed his cardiology and internal medicine training at Massachusetts General Hospital, the primary teaching hospital of Harvard University, and was a research fellow at Harvard Medical School. He earned a medical degree from Duke University School of Medicine, a Master of Public Health from Harvard University, and an undergraduate degree from the Johns Hopkins University

Career: Business and Pharmaceuticals
Coles joined Onyx in March 2008 as president, CEO and a member of the company’s board of directors. In 2009, Coles oversaw the acquisition of Proteolix, Inc., a a privately held bio-technology company. With the acquisition, Onyx gained rights to carfilzomib (marketed as Kyprolis for Injection). In 2012, he was named chairman of the board of directors of Onyx.

Prior to joining Onyx, he was president, CEO and a member of the board of directors of NPS Pharmaceuticals. Prior to NPS, he was a senior vice president of commercial operations at Vertex Pharmaceuticals, which he joined in 2002. He also has held positions at Bristol-Myers Squibb and Merck.

Academia and Non-Profit Organizations
Coles currently serves as a trustee and vice-chair for The Johns Hopkins University board of trustees, as well as a member of the board of trustees for Johns Hopkins Medicine. He is also a member of the board of the Biotechnology Industry Organization (BIO).

Awards
2012: 2011:
 * San Francisco Business Times Most Admired CEO
 * TheStreet.com: Finalist, Best Biotech CEO of 2012
 * MMRF Corporate Leadership Award
 * Named one of the 100 most inspiring people in the life-sciences industry in the annual PharmaVOICE 100 issue
 * Finalist in the 2011 Ernst & Young Entrepreneur of the Year Award in Northern California

Events and Panel Participation

 * BIO CEO Fireside Chat
 * Forbes Healthcare Summit
 * Deloitte and Gladstone Institute Presentation
 * Pharmaceutical Strategic Alliances Conference
 * Xconomy - Reinventing Biotech's Business Model
 * FasterCures
 * Aspen Ideas Festival
 * Milken Institute Panel: Philanthropy as Risk Capital